Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03921385 · ClinicalTrials.gov registry record
Augmented Reality Enhanced Surgery: Use of Holographic Technology in Cranial and Spinal Surgery
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 32
- Enrollment target
NCT03921385: Completed study, sponsored by University of Pennsylvania.
NCT03921385 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03921385 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
* To demonstrate the feasibility of integrating holographic technology as a heads-up display for navigated cranial and spinal neurosurgical procedures. This entails simply displaying the navigation screen currently used by Medtronic Stealth or Brainlab systems as a holographic image that can be positioned closer to the operative field. * To develop a systematic, efficient communication and registration process allowing holographic technology to be potentially utilized as a navigation tool in cranial and spinal neurosurgery. This entails developing software, optimizing connection parameters, and devising registration techniques incorporating line-of-sight fiducial markers to allow the holographic device to function as a navigation instrument.
Primary Outcome
To demonstrate the feasibility of integrating holographic technology as a heads-up display for navigated cranial and spinal neurosurgical procedures. This entails simply displaying the navigation screen currently used by Medtronic Stealth or Brainlab systems as a holographic image that can be positioned closer to the operative field.
Interventions
- DEVICE Augmented Reality Headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-02-22 |
| Est. Completion | 2022-07-14 |
What the finished NCT03921385 record still lists
NCT03921385 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Augmented Reality Headset is the first listed.
NCT03921385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03921385 about?
NCT03921385 is a clinical study titled "Augmented Reality Enhanced Surgery: Use of Holographic Technology in Cranial and Spinal Surgery". * To demonstrate the feasibility of integrating holographic technology as a heads-up display for navigated cranial and spinal neurosurgical procedures. This entails simply displaying the navigation screen currently used by Medtronic Stealth or Brainlab systems as a holographic image that can be posi...
What is the current status of trial NCT03921385?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2018-02-22. Estimated completion is 2022-07-14.
What interventions are being tested in trial NCT03921385?
The interventions under investigation include: Augmented Reality Headset (DEVICE).
Who is sponsoring clinical trial NCT03921385?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI